Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
暂无分享,去创建一个
N. Razavian | A. Moreira | N. Coudray | P. Ocampo | T. Sakellaropoulos | N. Narula | M. Snuderl | D. Fenyö | A. Tsirigos
[1] Jacob Cohen. A Coefficient of Agreement for Nominal Scales , 1960 .
[2] J. Hanley,et al. The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.
[3] R. Tibshirani,et al. An introduction to the bootstrap , 1993 .
[4] S. T. Buckland,et al. An Introduction to the Bootstrap. , 1994 .
[5] Robert F. Bonner,et al. Laser Capture Microdissection: Molecular Analysis of Tissue , 1997, Science.
[6] J. Vasiliev,et al. Changes in p53 expression can modify cell shape of ras-transformed fibroblasts and epitheliocytes , 1997, Oncogene.
[7] David Sidransky,et al. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. , 2002, Cancer research.
[8] U. Pastorino,et al. Quantification of Free Circulating DNA As a Diagnostic Marker in Lung Cancer , 2003 .
[9] Hans Clevers,et al. LKB1 tumor suppressor protein: PARtaker in cell polarity. , 2004, Trends in cell biology.
[10] J. Rigas,et al. Determinants of tumor response and survival with erlotinib in patients with non--small-cell lung cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Y. Yatabe,et al. EGFR Mutation Is Specific for Terminal Respiratory Unit Type Adenocarcinoma , 2005, The American journal of surgical pathology.
[12] M. Nordberg,et al. Cancer , 1906, The Hospital.
[13] M. Loda,et al. Mutation-Specific Antibodies for the Detection of EGFR Mutations in Non–Small-Cell Lung Cancer , 2009, Clinical Cancer Research.
[14] Mikhail Teverovskiy,et al. A systems pathology model for predicting overall survival in patients with refractory, advanced non-small-cell lung cancer treated with gefitinib. , 2009, European journal of cancer.
[15] A. Iafrate,et al. Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population , 2009, Clinical Cancer Research.
[16] Y. Ishikawa,et al. Correlation between morphology and EGFR mutations in lung adenocarcinomas Significance of the micropapillary pattern and the hobnail cell type. , 2009, Lung cancer.
[17] Samuel Leung,et al. Optimal Immunohistochemical Markers For Distinguishing Lung Adenocarcinomas From Squamous Cell Carcinomas in Small Tumor Samples , 2010, The American journal of surgical pathology.
[18] Gaël Varoquaux,et al. Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..
[19] T. Kohno,et al. Comprehensive Histologic Analysis of ALK-Rearranged Lung Carcinomas , 2011, The American journal of surgical pathology.
[20] Masahiro Tsuboi,et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[21] Akira Mogi,et al. TP53 Mutations in Nonsmall Cell Lung Cancer , 2011, Journal of biomedicine & biotechnology.
[22] S. Digumarthy,et al. Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors , 2011, Science Translational Medicine.
[23] S. Agarwal,et al. Standardization of epidermal growth factor receptor (EGFR) measurement by quantitative immunofluorescence and impact on antibody-based mutation detection in non-small cell lung cancer. , 2011, The American journal of pathology.
[24] Steven J. M. Jones,et al. Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.
[25] M. McHugh. Interrater reliability: the kappa statistic , 2012, Biochemia medica.
[26] A. Warth,et al. EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype , 2013, European Respiratory Journal.
[27] Benjamin J. Raphael,et al. Mutational landscape and significance across 12 major cancer types , 2013, Nature.
[28] Yi-long Wu,et al. Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap) , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[29] L. Liau,et al. Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation , 2013, Nature Genetics.
[30] Liu Wei,et al. LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin. , 2013, Cancer cell.
[31] Lucio Crinò,et al. Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study. , 2013, The Lancet. Oncology.
[32] Current status of targeted therapy in non-small cell lung cancer. , 2014, Drugs of today.
[33] Laurens van der Maaten,et al. Accelerating t-SNE using tree-based algorithms , 2014, J. Mach. Learn. Res..
[34] N. Pavlakis,et al. EGFR mutation specific immunohistochemistry is a useful adjunct which helps to identify false negative mutation testing in lung cancer , 2014, Pathology.
[35] Rob Fergus,et al. Visualizing and Understanding Convolutional Networks , 2013, ECCV.
[36] Michael den Bakker,et al. Prognostic and predictive biomarkers in lung cancer. A review , 2014, Virchows Archiv.
[37] D. Parums,et al. Current status of targeted therapy in non-small cell lung cancer. , 2014, Drugs of today.
[38] Steven J. M. Jones,et al. Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.
[39] Jürgen Schmidhuber,et al. Deep learning in neural networks: An overview , 2014, Neural Networks.
[40] Thomas J. Smith,et al. Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] Daniel L. Rubin,et al. Automated Grading of Gliomas using Deep Learning in Digital Pathology Images: A modular approach with ensemble of convolutional neural networks , 2015, AMIA.
[42] B. Chan,et al. Targeted therapy for non-small cell lung cancer: current standards and the promise of the future. , 2015, Translational lung cancer research.
[43] Dumitru Erhan,et al. Going deeper with convolutions , 2014, 2015 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).
[44] A. Churg,et al. Accuracy of classifying poorly differentiated non-small cell lung carcinoma biopsies with commonly used lung carcinoma markers. , 2015, Human pathology.
[45] Marios Anthimopoulos,et al. Lung Pattern Classification for Interstitial Lung Diseases Using a Deep Convolutional Neural Network , 2016, IEEE Transactions on Medical Imaging.
[46] Ronald M. Summers,et al. Deep Learning in Medical Imaging: Overview and Future Promise of an Exciting New Technique , 2016 .
[47] Sergey Ioffe,et al. Rethinking the Inception Architecture for Computer Vision , 2015, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).
[48] Julie M. Batten,et al. IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity. , 2016, Cancer research.
[49] Subhashini Venugopalan,et al. Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs. , 2016, JAMA.
[50] J. Jen,et al. Molecular characterization of pulmonary sarcomatoid carcinoma: analysis of 33 cases , 2016, Modern Pathology.
[51] N. Rajpoot,et al. Locality Sensitive Deep Learning for Detection and Classification of Nuclei in Routine Colon Cancer Histology Images , 2016, IEEE Transactions on Medical Imaging.
[52] D. Shen,et al. Computer-Aided Diagnosis with Deep Learning Architecture: Applications to Breast Lesions in US Images and Pulmonary Nodules in CT Scans , 2016, Scientific Reports.
[53] Nasir M. Rajpoot,et al. Locality Sensitive Deep Learning for Detection and Classification of Nuclei in Routine Colon Cancer Histology Images , 2016, IEEE Trans. Medical Imaging.
[54] Ce Zhang,et al. Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features , 2016, Nature Communications.
[55] Allison P. Heath,et al. Toward a Shared Vision for Cancer Genomic Data. , 2016, The New England journal of medicine.
[56] Lin Yang,et al. An Automatic Learning-Based Framework for Robust Nucleus Segmentation , 2016, IEEE Transactions on Medical Imaging.
[57] Junzhou Huang,et al. Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[58] Aren Jansen,et al. CNN architectures for large-scale audio classification , 2016, 2017 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP).
[59] Heung-Il Suk,et al. Deep Learning in Medical Image Analysis. , 2017, Annual review of biomedical engineering.
[60] Liron Pantanowitz,et al. Current State of the Regulatory Trajectory for Whole Slide Imaging Devices in the USA , 2017, Journal of pathology informatics.
[61] Ovidiu Daescu,et al. Histopathological Diagnosis for Viable and Non-viable Tumor Prediction for Osteosarcoma Using Convolutional Neural Network , 2017, ISBRA.
[62] K. Goldberg,et al. Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies , 2017, The oncologist.
[63] Anant Madabhushi,et al. Accurate and reproducible invasive breast cancer detection in whole-slide images: A Deep Learning approach for quantifying tumor extent , 2017, Scientific Reports.
[64] David B. A. Epstein,et al. Tumor Segmentation in Whole Slide Images Using Persistent Homology and Deep Convolutional Features , 2017, MIUA.
[65] Sebastian Thrun,et al. Dermatologist-level classification of skin cancer with deep neural networks , 2017, Nature.
[66] Thomas J. Smith,et al. Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[67] Geert J. S. Litjens,et al. Automatic segmentation of histopathological slides of renal tissue using deep learning , 2018, Medical Imaging.
[68] Rabi Yacoub,et al. Multi-radial LBP Features as a Tool for Rapid Glomerular Detection and Assessment in Whole Slide Histopathology Images , 2017, Scientific Reports.
[69] Andrew J. Schaumberg,et al. D R A F T H&E-stained Whole Slide Image Deep Learning Predicts SPOP Mutation State in Prostate Cancer , 2017 .
[70] Geert J. S. Litjens,et al. Automated segmentation of epithelial tissue in prostatectomy slides using deep learning , 2018, Medical Imaging.
[71] Ehsan Kazemi,et al. Deep Convolutional Neural Networks Enable Discrimination of Heterogeneous Digital Pathology Images , 2017, bioRxiv.